haloperidol has been researched along with osteoprotegerin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coon, D; Cowan, C; Gulati, A; He, J | 1 |
| Derijks, HJJ; Keijsers, CKJPW; Nanayakkara, PWB; Péquériaux, NC; Schrijver, EJM; van Marum, RJ; van Strien, AM | 1 |
1 trial(s) available for haloperidol and osteoprotegerin
| Article | Year |
|---|---|
Haloperidol Does Not Activate Thrombogenic Factors in Older, Nonpsychotic Hospitalized Patients.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Biomarkers; Fibrin Fibrinogen Degradation Products; Fibrinogen; Haloperidol; Humans; Osteoprotegerin; P-Selectin; Thrombosis; von Willebrand Factor | 2017 |
1 other study(ies) available for haloperidol and osteoprotegerin
| Article | Year |
|---|---|
The role of cyclooxygenase-2 (COX-2) in inflammatory bone resorption.
Topics: Acid Phosphatase; Aluminum Compounds; Animals; Biomarkers; Bone Resorption; Calcium Compounds; Cells, Cultured; Cyclooxygenase 2; Dinoprostone; Drug Combinations; Epoxy Resins; Female; Gutta-Percha; Inflammation Mediators; Isoenzymes; Lipopolysaccharides; Male; Mice; Mice, Knockout; Osteitis; Osteoblasts; Osteoclasts; Osteoprotegerin; Oxides; RANK Ligand; Root Canal Filling Materials; Silicates; Tartrate-Resistant Acid Phosphatase | 2007 |